The landscape of skin cancer treatment continues to change, with new research showing the potential to improve – and extend – the lives of those who continue to be affected by the disease.
CURE® reviewed some of the most widely read articles on melanoma in 2021, ranging from side effects and emotional well-being to survivor stories and the latest drug research. Here are the top five articles on skin cancer from the past year:
1. Skin cancer can impact emotional well-being
Skin cancer and its treatments can have an impact on physical and emotional well-being. This article provides insight from psychologist Maureen Sanger on how patients can cope with the psychosocial effects of a cancer diagnosis.
2. Stories of loss and survival with melanoma
CURE® contributor Robin Zimmerman has had melanoma having a significant impact on his life more than once. His wife was diagnosed with it in 2004, and after four years of treatment for the disease, died in 2008. Later in 2014, Zimmerman was diagnosed with early-stage melanoma which was removed. In this blog, he shares the two experiences. “Fear feeds prevention. Hope fuels diagnosis and treatment, ”he says.
3. Certain blood pressure medications can increase the risk of skin cancer
Thiazide diuretics, which are commonly used to lower high blood pressure, may increase the risk of skin cancer in people aged 66 or older, according to a study. Patients should talk to their healthcare team about the potential risks and personal and family history of cancer before starting treatment with any of these drugs.
4. Side Effects of Immune Checkpoint Inhibitors May Increase Hospitalizations and Costs for Skin Cancer Patients
Immunotherapy drugs have made significant improvements in the management of many types of cancer, including melanoma. However, since these checkpoint inhibitors activate the immune system to fight cancer, they have their own set of side effects that can lead to increased emergency room visits and higher healthcare costs.
5. Avastin Plus chemotherapy improves overall and progression-free survival in mucosal melanoma
Research published this year showed that adding Avastin (bevacizumab) to the chemotherapy drugs carboplatin and paclitaxel improved overall survival and progression-free survival (the time a patient lives without their disease getting worse) in people. with metastatic melanoma of the mucous membrane.
Keep up to date with the latest advancements in melanoma with the CURE® Skin Cancer page.
For more information on cancer updates, research and education, be sure to subscribe to CURE® newsletters here.